-
公开(公告)号:EP3271389B8
公开(公告)日:2020-04-22
申请号:EP16716979.6
申请日:2016-03-18
发明人: CONNORS, Mark , HUANG, Jinghe , KANG, Byong, Ha , MASCOLA, John , ISHIDA, Elise , ZHOU, Tongqing , KWONG, Peter , ZHENG, Anqi
-
公开(公告)号:EP3271389B1
公开(公告)日:2020-02-12
申请号:EP16716979.6
申请日:2016-03-18
发明人: CONNORS, Mark , HUANG, Jinghe , KANG, Byong, Ha , MASCOLA, John , ISHIDA, Elise , ZHOU, Tongqing , KWONG, Peter , ZHENG, Anqi
-
公开(公告)号:EP3271389A1
公开(公告)日:2018-01-24
申请号:EP16716979.6
申请日:2016-03-18
发明人: CONNORS, Mark , HUANG, Jinghe , KANG, Byong, Ha , MASCOLA, John , ISHIDA, Elise , ZHOU, Tongqing , KWONG, Peter , ZHENG, Anqi
CPC分类号: C07K16/1063 , A61K2039/505 , A61K2039/545 , A61P31/18 , C07K16/2809 , C07K16/468 , C07K2317/21 , C07K2317/31 , C07K2317/52 , C07K2317/76 , G01N33/56988 , G01N2333/162 , G01N2800/26
摘要: Antibodies and antigen binding fragments that specifically bind to gp120 and neutralize HIV-1 are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV-1 infection is disclosed.
-
-